Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
|Articles|May 4, 2021
Got a Bladder Cancer Question? Ask the Experts
Listen
0:00 / 0:00
Key Takeaways
- A one-hour live Q&A on May 26, 2021, offers bladder cancer patients direct access to expert clinical guidance.
- Faculty include Kent Mouw, MD, of Dana-Farber Cancer Institute and Sarah Psutka, MD, MSc, of the University of Washington.
Ask the Experts is a free, unique opportunity for bladder cancer patients and caregivers to interact online with two leading experts in the field.
Advertisement
On May 26, 2021, bladder cancer patients will have a unique opportunity to get their questions answered at our Ask the Experts event. As part of
During the hour long event, you will be able to ask questions of Dr. Kent Mouw of the Dana Farber Cancer Institute and Dr. Sarah Psutka of the University of Washington.
The winner of the inaugural
Registration is free, but required. Sign up today!
Advertisement
Related to this article
Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.
Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.
Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
3
Survivor Guilt After a Double Mastectomy for DCIS Breast Cancer
4
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
5